Prospective Assessment of Health-Related Quality of Life in Pediatric Patients with Beta-Thalassemia following Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 6, 2011, Pages 861-866

  Caocci, Giovanni ^a   Efficace, Fabio ^b   Ciotti, Francesca ^c   Roncarolo, Maria Grazia ^c   Vacca, Adriana ^a   Piras, Eugenia ^a   Littera, Roberto ^a   Dawood Markous, Raji Suleiman ^d   Collins, Gary Stephen ^e   Ciceri, Fabio ^c   Mandelli, Franco ^b   Marktel, Sarah ^c   La Nasa, Giorgio ^a,f  

^a Binaghi Hospital   (Italy)

^b Italian Group for Adult Hematologic Diseases GIMEMA Data Center   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d Thalassemia Center   (Iraq)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Child self report; Parent proxy report; Pediatric Quality of Life Inventory

Indexed keywords

ADOLESCENT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MORTALITY; OVERALL SURVIVAL; QUALITY OF LIFE; SELF REPORT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE EAST; PARENTS; PEDIATRICS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS;

EID: 79956038028     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.09.011     Document Type: Article

References (32)

1. Borgna-Pignatti C., Rugolotto S., De Stefano P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004, 89:1187-1193.
2. Borgna-Pignatti C. Surviving with thalassemia major: the Italian experience. Pediatr Hematol Oncol 2007, 24:75-78.
3. Rund D., Rachmilewitz E. β-Thalassemia. N Engl J Med 2005, 353:1135-1146.
4. Atkin K., Ahmad W. Living a " normal life": young people coping with thalassemia major or sickle cell disorder. Soc Sci Med 2001, 53:615-626.
5. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990, 322:417-421.
6. Lucarelli G., Giardini C., Angelucci E. Bone marrow transplantation in thalassemia. Cancer Treat Res 1997, 77:305-315.
7. Lucarelli G., Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008, 22:53-63.
8. La Nasa G., Giardini C., Argiolu F., et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002, 99:4350-4356.
9. Schumacher M., Olschewski M., Schulgen G. Assessment of quality of life in clinical trials. Stat Med 1991, 10:1915-1930.
10. Leplege A., Hunt S. The problem of quality of life in medicine. JAMA 1997, 278:47-50.
11. Efficace F., Sprangers M. Designing and interpreting quality-of-life and other patient-reported outcomes in clinical trials. Education Program for the 14th Congress of the European Hematology Association (EHA Educational Book 14) 2009, 89-95. European Hematology Association, Berlin, Germany.
12. Tefler P., Constantinidou G., Andreou P., et al. Quality of life in thalassemia. Ann N Y Acad Sci 2005, 1054:273-282.
13. Pakbaz Z., Treadwell M., Yamashita R., et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci 2005, 1054:457-461.
14. Dahlui M., Hishamshah M.I., Rahman A.J., et al. Quality of life in transfusion-dependent thalassemia patients on desferrioxamine treatment. Singapore Med J 2009, 50:794-799.
15. Scalone L., Mantovani L.G., Krol M. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin 2008, 24:1905-1917.
16. Ismail A., Campbell M.J., Ibrahim H.M., et al. Health-related quality of life in Malaysian children with thalassemia. Health Qual Life Outcomes 2006, 4:39-46.
17. Caocci G., Pisu S., Argiolu F., et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 2006, 37:165-169.
18. Cheuk D.K., Mok A.S., Lee A.C., et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008, 42:319-327.
19. Speechley K.N., Barrera M., Shaw A.K., et al. Health-related quality of life among child and adolescent survivors of childhood cancer. J Clin Oncol 2006, 24:2536-2543.
20. Forinder U., Lof C., Winiarski J. Quality of life following allogeneic stem cell transplantation, comparing parents' and children's perspective. Pediatr Transplant 2006, 10:491-496.
21. Barrera M., Atenafu E., Hancock K. Longitudinal health-related quality of life outcomes and related factors after pediatric SCT. Bone Marrow Transplant 2009, 44:249-256.
22. Thomas E.D., Storb R., Clift R.A., et al. Bone marrow transplant. N Engl J Med 1975, 292:832-843.
23. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
24. Varni J.W., Burwinkle T.M., Katz E.R., et al. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory generic core scales, mutidimensional fatigue scale, and cancer module. Cancer 2002, 94:2090-2106.
25. Varni J.W., Burwinkle T.M., Seid M. The PedsQL 4.0 as a school population measure: feasibility, reliability, and validity. Qual Life Res 2006, 15:203-215.
26. Varni JW. The PedsQL measurement model for the Pediatric Quality of Life Inventory. Available from: Accessed July 6, 2010. http://www.pedsql.org/about_pedsql.html.
27. World Health Organization. Measuring quality of life. Available from: Accessed July 6, 2010. http://www.who.int/evidence/assessement-instrument/QOL/index.ht/.
28. Borgna-Pignatti C. The life of patients with thalassemia major. Haematologica 2010, 3:345-348.
29. Clarke S.A., Eiser C., Skinner R. Health-related quality of life in survivors of BMT for pediatric malignancy: a systematic review of the literature. Bone Marrow Transplant 2008, 42:73-82.
30. Lucarelli G., Weatherall D.J. For debate: bone marrow transplantation for severe thalassaemia. Br J Haematol 1991, 78:300-303.
31. Weatherall D.J. The treatment of thalassemia: slow progress and new dilemmas. N Engl J Med 1993, 329:877-879.
32. Giardini C. Ethical issue of bone marrow transplantation for thalassemia (editorial). Bone Marrow Transplant 1995, 15:657-658.